It is saliva based genetic test which can be done from home and available at the cost of Rs 9,999 + taxes
Indus Health Plus is expanding its genetic testing portfolio by launching MEDNAwise, a genetic solution in precision medicine. MEDNAwise testing helps to understand which drug suits you best, manage your treatment and increase its effectiveness. MEDNAwise can also be used as predictive personalised medication guide.
The MEDNAwise testing is based on Pharmacogenomics, a study that uses genetic information to predict response to certain drugs/medicines. This can help the doctors prescribe safer & more effective medication.
Speaking around the launch Amol Naikawadi, Joint Managing Director, Indus Health Plus said “MEDNAwise can be taken by anyone with a personal or family history of adverse drug reaction(s), when the treatment is not giving results, those who are on multiple medications, elderly patients taking or starting certain specific medications. We have always tried to provide health care solutions to society and with the help of MEDNAwise we are taking a leap in personalised medication.”
It is saliva based genetic test which can be done from the home and available at the cost of Rs 9,999 + taxes. MEDNAwise is designed for all age groups and has 11 categories and 72 medicines covered related to different health departments. The categories covered under MEDNAwise testing are anesthesiology, neurology, cardiology, oncology, psychiatry, gastroenterology, gastroenterology, gynecology, organ transplantation, pulmonology, infectious disease.